Diseases (132)

Diagnostic Testing (55)


Evaluate cardiovascular risk.


Rule out hyperlipidemia.


Patients with DM have an increased incidence of lipid abnormalities, creating risk for CVD


Can be elevated in polycysitc ovarian syndrome (PCOS).



Lipid profiles may be deranged in a patient with ACS and lend little to the immediate diagnosis.


R/O pseudohyponatremia due to either elevated triglycerides or cholesterol.


Smokers usually have lower high-density lipoprotein cholesterol. Intern Med 2006;45(18):1027.

Disease Management Testing (54)



Patients with DM have an increased incidence of lipid abnormalities, creating risk for CVD


Patients should be screened annually for dyslipidemia after transplantation


If elevated, to monitor therapy.


Patients with DM have an increased incidence of lipid abnormalities, creating risk for CVD


Elevated LDL concentrations are common and may require therapy.


Evaluate for hyperlipidemia in patients treated with second generation anti-psychotics


The lipid profile, also known as the coronary risk panel, is comprised of total cholesterol, triglyceride, LDL-C (low density lipoprotein cholesterol), and HDL-C (high density lipoprotein cholesterol). It is usually used for evaluation of the risk for coronary heart disease and stroke. Testing lipid profile and especially cholesterol and cholesterol particles is the first step in screening for atherosclerosis risk, which might be the cause of heart attack and stroke. A heart attack or stroke is most commonly caused by blood vessels being blocked or by atherosclerosis (hardening of the arteries).

If through lipid testing it is discovered that a lipid disorder exists, treatments can be started to normalize lipid levels. Normalization can be achieved through medication, changes in diet, weight loss, and exercise. Therefore, this profile can be used as a screening test for risk evaluation for coronary heart disease and stroke, as well as diagnostic test for diagnosis and treatment monitoring of coronary heart disease, and familial hypercholesterolemia. It can be also used to monitor cholesterol and lipid-lowering lifestyle changes such as diet and exercise or to monitor cholesterol lowering drug therapy. Individuals with high blood pressure, tobacco smokers, individuals with a family history of cardiovascular disease, older people, and diabetes mellitus patients are at risk and should be screened. A more extended panel called NMR LipoProfile® test can be used for further screening and/or diagnosis. This test measures LDL particle number and size of LDL particles, as well as direct measurement of HDL and VLDL subclasses.

Cholesterol is a steroid, a waxy substance that is found in the blood, tissues, and organs of all mammals including humans. Cholesterol is synthesized mainly in the liver. Metabolized cholesterol accounts for 75% of the cholesterol level, and diet accounts for the other 25%. Total cholesterol level in the body is dependent on many factors such as diet, liver function, lipid metabolism, heredity, and lifestyle choices. Testing serum cholesterol is the first step in screening for atherosclerosis risk.

Triglycerides are stored in the fat cells of the body and serve as a main source of body energy. Triglycerides are absorbed in the intestine and are also synthesized in the liver. Elevated triglycerides are now considered an independent risk factor for coronary artery disease, and a major risk factor for acute pancreatitis, particularly when serum triglyceride levels are >1000 mg/dL.

High density lipoproteins (HDL)
HDL is responsible for the transport of cholesterol from the peripheral cells to the liver, where it is converted to bile acids which are excreted into the intestine via the biliary tract. Elevated HDL concentrations are protective against coronary heart disease, while reduced HDL concentrations indicate increased cardiovascular risk.

Low-density lipoprotein (LDL)
LDL belongs to a group of lipoproteins which serve as a transporter for cholesterol and lipids. Testing for LDL is used to evaluate the risk for coronary heart disease and stroke. High levels are associated with an increased risk of atherosclerosis and coronary heart disease and stroke.

Clinical Utility

  • Evaluate the risk for coronary heart disease
  • Diagnosis of Atherosclerosis (arteriosclerotic vascular disease)
  • Diagnosis of familial hypercholesterolemia
  • Used to evaluate the effectiveness of drug therapy (cholesterol lowering drugs)
  • As an aid in evaluation of diabetes mellitus, nephrotic syndrome, and liver disease with biliary obstruction
  • As an aid in evaluation of fatty liver in chronic alcoholism
  • As an aid in diagnosis of lipoproteinemia due to lipase deficiency
  • Monitoring drug treatment therapy


Increased in:

  • Coronary heart disease and stroke
  • Familial hypercholesterolemia
  • Familial combined hyperlipidemia
  • Atherosclerotic coronary artery disease
  • Hypertension
  • Hypothyroidism
  • Uncontrolled diabetes mellitus
  • Nephrotic syndrome
  • Liver disorders such as biliary obstruction and hepatocellular carcinoma
  • Cushing’s syndrome
  • Acute intermittent porphyria
  • Chronic alcoholism (fatty liver)
  • Biliary tract obstruction
  • Familial lipoprotein lipase deficiency
  • Familial dysbetalipoproteinemia
  • Obesity
  • Use of corticosteroids

Decreased in:

  • Severe liver disease (acute hepatitis, cirrhosis, malignancy)
  • Hyperthyroidism
  • Severe, acute, or chronic illness
  • Malnutrition and malabsorption
  • Extensive burns
  • Gaucher’s disease
  • Tangier disease (lipoprotein deficiency)
  • Hypolipoproteinemia and abetalipoproteinemia
  • Malnutrition
  • Decreased in use of some drugs such as: ascorbic acid, clofibrate, nicotinic acid, gemfibrozil

Reference Ranges

Element Optimal Borderline High risk
LDL Cholesterol <100 130-159 160+
HDL Cholesterol >60 35-45 <35
Triglycerides <150 150-199 >200
Total Cholesterol <200 200-239 >240
Cholesterol:HDL Ratio <4 5 >6


RIA (Radioimmunoassay), ELISA (Enzyme-Linked Immunosorbent Assay), RID (Radial ImmunoDiffusion), Enzymatic, Colorimetric methods to separate LDL, HDL and Triglycerides. Refer to individual laboratory methods.

Specimen Collection

Serum (SST)

Red top acceptable. 1 mL minimum. 12 hour fasting. No alcohol 24 hours prior to draw.


  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 30 days

Additional Testing

Apolipoprotein A-I, Apolipoprotein B-100, C-reactive protein (CRP), Homocysteine, VLDL-C (very low density lipoprotein cholesterol), NMR Lipo profile, Liver panel, Comprehensive metabolic panel, CBC.

Turnaround Time

1-3 days.




B20Human immunodeficiency virus [HIV] disease
C74Malignant neoplasm of adrenal gland
C74.0Malignant neoplasm of cortex of adrenal gland
C74.00Malignant neoplasm of cortex of unspecified adrenal gland
C74.01Malignant neoplasm of cortex of right adrenal gland
C74.02Malignant neoplasm of cortex of left adrenal gland
C74.1Malignant neoplasm of medulla of adrenal gland
C74.10Malignant neoplasm of medulla of unspecified adrenal gland
C74.11Malignant neoplasm of medulla of right adrenal gland
C74.12Malignant neoplasm of medulla of left adrenal gland
C74.9Malignant neoplasm of unspecified part of adrenal gland
C74.90Malignant neoplasm of unspecified part of unspecified adrenal gland
C74.91Malignant neoplasm of unspecified part of right adrenal gland
C74.92Malignant neoplasm of unspecified part of left adrenal gland
D13Benign neoplasm of other and ill-defined parts of digestive system
D13.6Benign neoplasm of pancreas
D35.0Benign neoplasm of adrenal gland
D35.00Benign neoplasm of unspecified adrenal gland
D3ABenign neuroendocrine tumors
D3A.8Other benign neuroendocrine tumors
D49.7Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
E00Congenital iodine-deficiency syndrome
E00.9Congenital iodine-deficiency syndrome, unspecified
E01.0Iodine-deficiency related diffuse (endemic) goiter
E02Subclinical iodine-deficiency hypothyroidism
E03Other hypothyroidism
E03.0Congenital hypothyroidism with diffuse goiter
E03.1Congenital hypothyroidism without goiter
E03.2Hypothyroidism due to medicaments and other exogenous substances
E03.3Postinfectious hypothyroidism
E03.8Other specified hypothyroidism
E03.9Hypothyroidism, unspecified
E04Other nontoxic goiter
E04.2Nontoxic multinodular goiter
E04.9Nontoxic goiter, unspecified
E05Thyrotoxicosis [hyperthyroidism]
E05.0Thyrotoxicosis with diffuse goiter
E05.1Thyrotoxicosis with toxic single thyroid nodule
E05.8Other thyrotoxicosis
E05.9Thyrotoxicosis, unspecified
E06.0Acute thyroiditis
E06.1Subacute thyroiditis
E06.2Chronic thyroiditis with transient thyrotoxicosis
E06.3Autoimmune thyroiditis
E06.4Drug-induced thyroiditis
E06.5Other chronic thyroiditis
E06.9Thyroiditis, unspecified
E08Diabetes mellitus due to underlying condition
E08.21Diabetes mellitus due to underlying condition with diabetic nephropathy
E08.69Diabetes mellitus due to underlying condition with other specified complication
E08.8Diabetes mellitus due to underlying condition with unspecified complications
E08.9Diabetes mellitus due to underlying condition without complications
E10Type 1 diabetes mellitus
E10.1Type 1 diabetes mellitus with ketoacidosis
E10.8Type 1 diabetes mellitus with unspecified complications
E10.9Type 1 diabetes mellitus without complications
E11Type 2 diabetes mellitus
E11.69Type 2 diabetes mellitus with other specified complication
E11.8Type 2 diabetes mellitus with unspecified complications
E11.9Type 2 diabetes mellitus without complications
E13Other specified diabetes mellitus
E13.2Other specified diabetes mellitus with kidney complications
E13.21Other specified diabetes mellitus with diabetic nephropathy
E13.22Other specified diabetes mellitus with diabetic chronic kidney disease
E13.29Other specified diabetes mellitus with other diabetic kidney complication
E13.9Other specified diabetes mellitus without complications
E22Hyperfunction of pituitary gland
E22.0Acromegaly and pituitary gigantism
E22.8Other hyperfunction of pituitary gland
E22.9Hyperfunction of pituitary gland, unspecified
E26.1Secondary hyperaldosteronism
E26.8Other hyperaldosteronism
E26.9Hyperaldosteronism, unspecified
E27.5Adrenomedullary hyperfunction
E28.2Polycystic ovarian syndrome
E28.31Premature menopause
E28.310Symptomatic premature menopause
E34.4Constitutional tall stature
E44Protein-calorie malnutrition of moderate and mild degree
E44.0Moderate protein-calorie malnutrition
E44.1Mild protein-calorie malnutrition
E61Deficiency of other nutrient elements
E65Localized adiposity
E66Overweight and obesity
E66.0Obesity due to excess calories
E66.09Other obesity due to excess calories
E66.8Other obesity
E66.9Obesity, unspecified
E70Disorders of aromatic amino-acid metabolism
E72Other disorders of amino-acid metabolism
E72.9Disorder of amino-acid metabolism, unspecified
E74Other disorders of carbohydrate metabolism
E74.0Glycogen storage disease
E74.00Glycogen storage disease, unspecified
E74.01von Gierke disease
E74.02Pompe disease
E74.09Other glycogen storage disease
E75.0GM2 gangliosidosis
E75.00GM2 gangliosidosis, unspecified
E75.24Niemann-Pick disease
E75.240Niemann-Pick disease type A
E75.241Niemann-Pick disease type B
E75.242Niemann-Pick disease type C
E75.243Niemann-Pick disease type D
E75.248Other Niemann-Pick disease
E75.249Niemann-Pick disease, unspecified
E78Disorders of lipoprotein metabolism and other lipidemias
E78.0Pure hypercholesterolemia
E78.1Pure hyperglyceridemia
E78.2Mixed hyperlipidemia
E78.4Other hyperlipidemia
E78.5Hyperlipidemia, unspecified
E78.6Lipoprotein deficiency
E78.8Other disorders of lipoprotein metabolism
E78.89Other lipoprotein metabolism disorders
E78.9Disorder of lipoprotein metabolism, unspecified
E83.110Hereditary hemochromatosis
E83.111Hemochromatosis due to repeated red blood cell transfusions
E83.118Other hemochromatosis
E83.119Hemochromatosis, unspecified
E87.1Hypo-osmolality and hyponatremia
E88Other and unspecified metabolic disorders
E88.81Metabolic syndrome
E88.9Metabolic disorder, unspecified
E89.0Postprocedural hypothyroidism
F06.4Anxiety disorder due to known physiological condition
F17Nicotine dependence
F40Phobic anxiety disorders
F41Other anxiety disorders
F41.1Generalized anxiety disorder
F41.3Other mixed anxiety disorders
F41.9Anxiety disorder, unspecified
F43.1Post-traumatic stress disorder (PTSD)
F43.10Post-traumatic stress disorder, unspecified
F43.11Post-traumatic stress disorder, acute
F43.12Post-traumatic stress disorder, chronic
F98Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence
G08Intracranial and intraspinal phlebitis and thrombophlebitis
G11.1Early-onset cerebellar ataxia
G11.2Late-onset cerebellar ataxia
G45.1Carotid artery syndrome (hemispheric)
G45.3Amaurosis fugax
G45.9Transient cerebral ischemic attack, unspecified
G46.4Cerebellar stroke syndrome
I01.9Acute rheumatic heart disease, unspecified
I10Essential (primary) hypertension
I11.0Hypertensive heart disease with heart failure
I12Hypertensive chronic kidney disease
I13Hypertensive heart and chronic kidney disease
I15Secondary hypertension
I15.2Hypertension secondary to endocrine disorders
I15.8Other secondary hypertension
I15.9Secondary hypertension, unspecified
I20Angina pectoris
I20.0Unstable angina
I20.1Angina pectoris with documented spasm
I20.8Other forms of angina pectoris
I20.9Angina pectoris, unspecified
I21Acute myocardial infarction
I21.0ST elevation (STEMI) myocardial infarction of anterior wall
I21.1ST elevation (STEMI) myocardial infarction of inferior wall
I21.2ST elevation (STEMI) myocardial infarction of other sites
I21.3ST elevation (STEMI) myocardial infarction of unspecified site
I21.4Non-ST elevation (NSTEMI) myocardial infarction
I22Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
I23.7Postinfarction angina
I23.8Other current complications following acute myocardial infarction
I24Other acute ischemic heart diseases
I24.0Acute coronary thrombosis not resulting in myocardial infarction
I24.8Other forms of acute ischemic heart disease
I24.9Acute ischemic heart disease, unspecified
I25Chronic ischemic heart disease
I25.1Atherosclerotic heart disease of native coronary artery
I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
I25.11Atherosclerotic heart disease of native coronary artery with angina pectoris
I25.2Old myocardial infarction
I25.3Aneurysm of heart
I25.41Coronary artery aneurysm
I25.42Coronary artery dissection
I25.5Ischemic cardiomyopathy
I25.7Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris
I25.8Other forms of chronic ischemic heart disease
I25.9Chronic ischemic heart disease, unspecified
I34Nonrheumatic mitral valve disorders
I41Myocarditis in diseases classified elsewhere
I48Atrial fibrillation and flutter
I48.0Paroxysmal atrial fibrillation
I48.1Persistent atrial fibrillation
I48.2Chronic atrial fibrillation
I48.9Unspecified atrial fibrillation and atrial flutter
I48.91Unspecified atrial fibrillation
I50Heart failure
I50.20Unspecified systolic (congestive) heart failure
I50.21Acute systolic (congestive) heart failure
I50.22Chronic systolic (congestive) heart failure
I50.23Acute on chronic systolic (congestive) heart failure
I50.30Unspecified diastolic (congestive) heart failure
I50.31Acute diastolic (congestive) heart failure
I50.32Chronic diastolic (congestive) heart failure
I50.33Acute on chronic diastolic (congestive) heart failure
I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
I50.9Heart failure, unspecified
I51Complications and ill-defined descriptions of heart disease
I51.9Heart disease, unspecified
I61Nontraumatic intracerebral hemorrhage
I61.9Nontraumatic intracerebral hemorrhage, unspecified
I62Other and unspecified nontraumatic intracranial hemorrhage
I62.0Nontraumatic subdural hemorrhage
I63Cerebral infarction
I63.0Cerebral infarction due to thrombosis of precerebral arteries
I63.00Cerebral infarction due to thrombosis of unspecified precerebral artery
I63.8Other cerebral infarction
I63.9Cerebral infarction, unspecified
I65.21Occlusion and stenosis of right carotid artery
I65.22Occlusion and stenosis of left carotid artery
I65.23Occlusion and stenosis of bilateral carotid arteries
I65.29Occlusion and stenosis of unspecified carotid artery
I66Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
I66.3Occlusion and stenosis of cerebellar arteries
I66.9Occlusion and stenosis of unspecified cerebral artery
I67Other cerebrovascular diseases
I67.1Cerebral aneurysm, nonruptured
I67.2Cerebral atherosclerosis
I67.82Cerebral ischemia
I70.0Atherosclerosis of aorta
I70.91Generalized atherosclerosis
I87.39Chronic venous hypertension (idiopathic) with other complications
I95.0Idiopathic hypotension
I99Other and unspecified disorders of circulatory system
K52Other and unspecified noninfective gastroenteritis and colitis
K70Alcoholic liver disease
K70.0Alcoholic fatty liver
K70.1Alcoholic hepatitis
K70.3Alcoholic cirrhosis of liver
K70.30Alcoholic cirrhosis of liver without ascites
K70.31Alcoholic cirrhosis of liver with ascites
K70.4Alcoholic hepatic failure
K72Hepatic failure, not elsewhere classified
K72.00Acute and subacute hepatic failure without coma
K72.01Acute and subacute hepatic failure with coma
K72.11Chronic hepatic failure with coma
K72.90Hepatic failure, unspecified without coma
K72.91Hepatic failure, unspecified with coma
K73Chronic hepatitis, not elsewhere classified
K74Fibrosis and cirrhosis of liver
K74.0Hepatic fibrosis
K74.3Primary biliary cirrhosis
K74.5Biliary cirrhosis, unspecified
K74.6Other and unspecified cirrhosis of liver
K74.60Unspecified cirrhosis of liver
K74.69Other cirrhosis of liver
K75.81Nonalcoholic steatohepatitis (NASH)
K76.0Fatty (change of) liver, not elsewhere classified
K76.89Other specified diseases of liver
K76.9Liver disease, unspecified
K80.0Calculus of gallbladder with acute cholecystitis
K83.1Obstruction of bile duct
K85Acute pancreatitis
K85.0Idiopathic acute pancreatitis
K85.1Biliary acute pancreatitis
K85.2Alcohol induced acute pancreatitis
K85.3Drug induced acute pancreatitis
K85.8Other acute pancreatitis
K85.9Acute pancreatitis, unspecified
K86Other diseases of pancreas
K86.0Alcohol-induced chronic pancreatitis
K86.1Other chronic pancreatitis
K86.8Other specified diseases of pancreas
K86.9Disease of pancreas, unspecified
K90Intestinal malabsorption
K90.8Other intestinal malabsorption
K90.89Other intestinal malabsorption
K90.9Intestinal malabsorption, unspecified
K91.2Postsurgical malabsorption, not elsewhere classified
L83Acanthosis nigricans
M30.3Mucocutaneous lymph node syndrome [Kawasaki]
M32Systemic lupus erythematosus (SLE)
M32.1Systemic lupus erythematosus with organ or system involvement
M32.10Systemic lupus erythematosus, organ or system involvement unspecified
M33.0Juvenile dermatomyositis
M33.1Other dermatomyositis
M33.9Dermatopolymyositis, unspecified
N00Acute nephritic syndrome
N00.3Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
N00.9Acute nephritic syndrome with unspecified morphologic changes
N03Chronic nephritic syndrome
N03.2Chronic nephritic syndrome with diffuse membranous glomerulonephritis
N03.5Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
N03.7Chronic nephritic syndrome with diffuse crescentic glomerulonephritis
N03.9Chronic nephritic syndrome with unspecified morphologic changes
N04Nephrotic syndrome
N04.8Nephrotic syndrome with other morphologic changes
N04.9Nephrotic syndrome with unspecified morphologic changes
N05Unspecified nephritic syndrome
N05.2Unspecified nephritic syndrome with diffuse membranous glomerulonephritis
N05.5Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
N08Glomerular disorders in diseases classified elsewhere
N10Acute pyelonephritis
N13Obstructive and reflux uropathy
N18Chronic kidney disease (CKD)
N18.9Chronic kidney disease, unspecified
N23Unspecified renal colic
N26.9Renal sclerosis, unspecified
N28Other disorders of kidney and ureter, not elsewhere classified
N28.1Cyst of kidney, acquired
N83.20Unspecified ovarian cysts
N95Menopausal and other perimenopausal disorders
N95.0Postmenopausal bleeding
N95.1Menopausal and female climacteric states
N95.2Postmenopausal atrophic vaginitis
N95.8Other specified menopausal and perimenopausal disorders
N95.9Unspecified menopausal and perimenopausal disorder
N97Female infertility
N97.9Female infertility, unspecified
O09Supervision of high risk pregnancy
O09.0Supervision of pregnancy with history of infertility
O24.02Pre-existing type 1 diabetes mellitus, in childbirth
O24.1Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium
O24.4Gestational diabetes mellitus
O24.41Gestational diabetes mellitus in pregnancy
O26Maternal care for other conditions predominantly related to pregnancy
O36.01Maternal care for anti-D [Rh] antibodies
O90.5Postpartum thyroiditis
O98.71Human immunodeficiency virus [HIV] disease complicating pregnancy
O99.01Anemia complicating pregnancy
O99.280Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester
P04.2Newborn affected by maternal use of tobacco
Q61Cystic kidney disease
Q61.02Congenital multiple renal cysts
Q61.3Polycystic kidney, unspecified
Q61.9Cystic kidney disease, unspecified
Q87Other specified congenital malformation syndromes affecting multiple systems
Q87.1Congenital malformation syndromes predominantly associated with short stature
R03Abnormal blood-pressure reading, without diagnosis
R42Dizziness and giddiness
R54Age-related physical debility
R73Elevated blood glucose level
R75Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
R77Other abnormalities of plasma proteins
R94.31Abnormal electrocardiogram [ECG] [EKG]
R94.39Abnormal result of other cardiovascular function study
R94.4Abnormal results of kidney function studies
R94.6Abnormal results of thyroid function studies
T86.4Complications of liver transplant
T86.40Unspecified complication of liver transplant
T86.41Liver transplant rejection
T86.42Liver transplant failure
T86.43Liver transplant infection
T86.49Other complications of liver transplant
Z00Encounter for general examination without complaint, suspected or reported diagnosis
Z00.0Encounter for general adult medical examination
Z00.00Encounter for general adult medical examination without abnormal findings
Z00.01Encounter for general adult medical examination with abnormal findings
Z00.8Encounter for other general examination
Z01.41Encounter for routine gynecological examination
Z01.411Encounter for gynecological examination (general) (routine) with abnormal findings
Z01.810Encounter for preprocedural cardiovascular examination
Z11.4Encounter for screening for human immunodeficiency virus [HIV]
Z12.10Encounter for screening for malignant neoplasm of intestinal tract, unspecified
Z13.1Encounter for screening for diabetes mellitus
Z13.21Encounter for screening for nutritional disorder
Z13.22Encounter for screening for metabolic disorder
Z13.220Encounter for screening for lipoid disorders
Z13.228Encounter for screening for other metabolic disorders
Z13.6Encounter for screening for cardiovascular disorders
Z13.7Encounter for screening for genetic and chromosomal anomalies
Z13.71Encounter for nonprocreative screening for genetic disease carrier status
Z14Genetic carrier
Z20Contact with and (suspected) exposure to communicable diseases
Z20.6Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Z21Asymptomatic human immunodeficiency virus [HIV] infection status
Z30.014Encounter for initial prescription of intrauterine contraceptive device
Z30.8Encounter for other contraceptive management
Z31.430Encounter of female for testing for genetic disease carrier status for procreative management
Z31.440Encounter of male for testing for genetic disease carrier status for procreative management
Z31.5Encounter for procreative genetic counseling
Z31.81Encounter for male factor infertility in female patient
Z34Encounter for supervision of normal pregnancy
Z34.8Encounter for supervision of other normal pregnancy
Z48.23Encounter for aftercare following liver transplant
Z68Body mass index [BMI]
Z72.0Tobacco use
Z77Other contact with and (suspected) exposures hazardous to health
Z77.120Contact with and (suspected) exposure to mold (toxic)
Z78.0Asymptomatic menopausal state
Z81.2Family history of tobacco abuse and dependence
Z82.3Family history of stroke
Z82.4Family history of ischemic heart disease and other diseases of the circulatory system
Z82.49Family history of ischemic heart disease and other diseases of the circulatory system
Z82.71Family history of polycystic kidney
Z83.0Family history of human immunodeficiency virus [HIV] disease
Z83.3Family history of diabetes mellitus
Z83.49Family history of other endocrine, nutritional and metabolic diseases
Z84.81Family history of carrier of genetic disease
Z85.85Personal history of malignant neoplasm of endocrine glands
Z85.9Personal history of malignant neoplasm, unspecified
Z86.69Personal history of other diseases of the nervous system and sense organs
Z86.73Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
Z86.79Personal history of other diseases of the circulatory system
Z87.891Personal history of nicotine dependence
Z94.4Liver transplant status


  • J Atheroscler Thromb. 2011 Nov 30. [PMID:22129522]
  • Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):155-60. [PMID:17206389]
  • JAMA. 2001 May 16;285(19):2486-97. [PMID:11368702]
  • Compr Ther. 1996 Aug;22(8):492-500. [PMID:8879916]
  • Geriatr Nurs. 2006 May-Jun;27(3):142-8. [PMID:16757384]
  • J Am Acad Nurse Pract. 2003 Aug;15(8):350-60. [PMID:14509100]
  • Mayo Clinic Proc. 2006;81:1225. [PMID:16970219]
  • Med Gen Med. 2006;8:54. [PMID:16915184]
  • Curr Atheroscler Rep. 2001 Sep;3(5):404-11. [PMID:11565569]
  • Clin Chem Lab Med. 2000 Apr;38(4):287-300. [PMID:10928647]
  • Endocrinol Metab Clin North Am. 2009 Mar;38(1):137-49. [PMID:19217516]
  • Am J Med Sci. 2005;330:295. [PMID:16355014]
  • Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier (2006). Pp. 351-356
  • Jacobs DS, DeMott WR, Oxley DK. Laboratory Test Handbook, fifth edition, Lexi-COMP, Inc (2004). Pp. 212-213.